Cytolytic T lymphocyte clones in anti-viral immunity

Effector function in vivo and mechanism of action

T. J. Braciale, Aron Lukacher, M. T. Sweetser, V. L. Braciale

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Table 2 SPECIFICITY OF PULMONARY VIRUS REDUCTION BY CTL CLONE Table 3 H-2 RESTRICTION OF RECOVERY MEDIATED BY CLONE A7 A/MEL/35 infected mice (Figure IB). The in vitro protective function of these cloned cells correlated with their capacity to eliminate infectious virus from the lungs of lethally infected recipient mice. As Table 2 demonstrates, clone A4 reduced pulmonary virus titers at day 5 after infection in an antigen-specific manner. This effect on virus titer paralleled the in vitro antigenic specificity of the clone and the specificity of its protective effect in vivo. Recovered mice showed no gross evidence of residual pulmonary pathology when lungs were examined at 21 to 28 days after infection. Thus, these cloned CTL which had been maintained in continuous in vitro culture for up to a year could reduce pulmonary virus titers and promote recovery from lethal infection in a fashion analogous to conventional heterogeneous CTL populations.

Original languageEnglish (US)
Title of host publicationCytolytic Lymphocytes and Complement Effectors of the Immune System
PublisherCRC Press
Pages161-174
Number of pages14
Volume2
ISBN (Electronic)9781351079747
ISBN (Print)084936969X, 9781315892191
DOIs
StatePublished - Jan 1 2018

Fingerprint

Immunity
Clone Cells
T-Lymphocytes
Lung
Viral Load
Infection
Viruses
Epitopes
Pathology
Antigens
Population
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Health Professions(all)
  • Medicine(all)

Cite this

Braciale, T. J., Lukacher, A., Sweetser, M. T., & Braciale, V. L. (2018). Cytolytic T lymphocyte clones in anti-viral immunity: Effector function in vivo and mechanism of action. In Cytolytic Lymphocytes and Complement Effectors of the Immune System (Vol. 2, pp. 161-174). CRC Press. https://doi.org/10.1201/9781351071291
Braciale, T. J. ; Lukacher, Aron ; Sweetser, M. T. ; Braciale, V. L. / Cytolytic T lymphocyte clones in anti-viral immunity : Effector function in vivo and mechanism of action. Cytolytic Lymphocytes and Complement Effectors of the Immune System. Vol. 2 CRC Press, 2018. pp. 161-174
@inbook{fcad681e2e75498bb4619e1bfd694a7b,
title = "Cytolytic T lymphocyte clones in anti-viral immunity: Effector function in vivo and mechanism of action",
abstract = "Table 2 SPECIFICITY OF PULMONARY VIRUS REDUCTION BY CTL CLONE Table 3 H-2 RESTRICTION OF RECOVERY MEDIATED BY CLONE A7 A/MEL/35 infected mice (Figure IB). The in vitro protective function of these cloned cells correlated with their capacity to eliminate infectious virus from the lungs of lethally infected recipient mice. As Table 2 demonstrates, clone A4 reduced pulmonary virus titers at day 5 after infection in an antigen-specific manner. This effect on virus titer paralleled the in vitro antigenic specificity of the clone and the specificity of its protective effect in vivo. Recovered mice showed no gross evidence of residual pulmonary pathology when lungs were examined at 21 to 28 days after infection. Thus, these cloned CTL which had been maintained in continuous in vitro culture for up to a year could reduce pulmonary virus titers and promote recovery from lethal infection in a fashion analogous to conventional heterogeneous CTL populations.",
author = "Braciale, {T. J.} and Aron Lukacher and Sweetser, {M. T.} and Braciale, {V. L.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1201/9781351071291",
language = "English (US)",
isbn = "084936969X",
volume = "2",
pages = "161--174",
booktitle = "Cytolytic Lymphocytes and Complement Effectors of the Immune System",
publisher = "CRC Press",

}

Braciale, TJ, Lukacher, A, Sweetser, MT & Braciale, VL 2018, Cytolytic T lymphocyte clones in anti-viral immunity: Effector function in vivo and mechanism of action. in Cytolytic Lymphocytes and Complement Effectors of the Immune System. vol. 2, CRC Press, pp. 161-174. https://doi.org/10.1201/9781351071291

Cytolytic T lymphocyte clones in anti-viral immunity : Effector function in vivo and mechanism of action. / Braciale, T. J.; Lukacher, Aron; Sweetser, M. T.; Braciale, V. L.

Cytolytic Lymphocytes and Complement Effectors of the Immune System. Vol. 2 CRC Press, 2018. p. 161-174.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Cytolytic T lymphocyte clones in anti-viral immunity

T2 - Effector function in vivo and mechanism of action

AU - Braciale, T. J.

AU - Lukacher, Aron

AU - Sweetser, M. T.

AU - Braciale, V. L.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Table 2 SPECIFICITY OF PULMONARY VIRUS REDUCTION BY CTL CLONE Table 3 H-2 RESTRICTION OF RECOVERY MEDIATED BY CLONE A7 A/MEL/35 infected mice (Figure IB). The in vitro protective function of these cloned cells correlated with their capacity to eliminate infectious virus from the lungs of lethally infected recipient mice. As Table 2 demonstrates, clone A4 reduced pulmonary virus titers at day 5 after infection in an antigen-specific manner. This effect on virus titer paralleled the in vitro antigenic specificity of the clone and the specificity of its protective effect in vivo. Recovered mice showed no gross evidence of residual pulmonary pathology when lungs were examined at 21 to 28 days after infection. Thus, these cloned CTL which had been maintained in continuous in vitro culture for up to a year could reduce pulmonary virus titers and promote recovery from lethal infection in a fashion analogous to conventional heterogeneous CTL populations.

AB - Table 2 SPECIFICITY OF PULMONARY VIRUS REDUCTION BY CTL CLONE Table 3 H-2 RESTRICTION OF RECOVERY MEDIATED BY CLONE A7 A/MEL/35 infected mice (Figure IB). The in vitro protective function of these cloned cells correlated with their capacity to eliminate infectious virus from the lungs of lethally infected recipient mice. As Table 2 demonstrates, clone A4 reduced pulmonary virus titers at day 5 after infection in an antigen-specific manner. This effect on virus titer paralleled the in vitro antigenic specificity of the clone and the specificity of its protective effect in vivo. Recovered mice showed no gross evidence of residual pulmonary pathology when lungs were examined at 21 to 28 days after infection. Thus, these cloned CTL which had been maintained in continuous in vitro culture for up to a year could reduce pulmonary virus titers and promote recovery from lethal infection in a fashion analogous to conventional heterogeneous CTL populations.

UR - http://www.scopus.com/inward/record.url?scp=84913034661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84913034661&partnerID=8YFLogxK

U2 - 10.1201/9781351071291

DO - 10.1201/9781351071291

M3 - Chapter

SN - 084936969X

SN - 9781315892191

VL - 2

SP - 161

EP - 174

BT - Cytolytic Lymphocytes and Complement Effectors of the Immune System

PB - CRC Press

ER -

Braciale TJ, Lukacher A, Sweetser MT, Braciale VL. Cytolytic T lymphocyte clones in anti-viral immunity: Effector function in vivo and mechanism of action. In Cytolytic Lymphocytes and Complement Effectors of the Immune System. Vol. 2. CRC Press. 2018. p. 161-174 https://doi.org/10.1201/9781351071291